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The protein product of the ocular albinism type 1 gene, named OA1, is a pigment cell-specific G protein-
coupled receptor exclusively localized to intracellular organelles, namely lysosomes and melanosomes.
Loss of OA1 function leads to the formation of macromelanosomes, suggesting that this receptor is implicated
in organelle biogenesis, however the mechanism involved in the pathogenesis of the disease remains obscure.
We report here the identification of an unexpected abnormality in melanosome distribution both in retinal
pigment epithelium (RPE) and skin melanocytes of Oa1-knock-out (KO) mice, consisting in a displacement
of the organelles from the central cytoplasm towards the cell periphery. Despite their depletion from the micro-
tubule (MT)-enriched perinuclear region,Oa1-KO melanosomes were able to aggregate at the centrosome upon
disruption of the actin cytoskeleton or expression of a dominant-negative construct of myosin Va. Consistently,
quantification of organelle transport in living cells revealed that Oa1-KO melanosomes displayed a severe
reduction in MT-based motility; however, this defect was rescued to normal following inhibition of actin-depen-
dent capture at the cell periphery. Together, these data point to a defective regulation of organelle transport in
the absence of OA1 and imply that the cytoskeleton might represent a downstream effector of this receptor.
Furthermore, our results enlighten a novel function for OA1 in pigment cells and suggest that ocular albinism
type 1 might result from a different pathogenetic mechanism than previously thought, based on an organelle-
autonomous signalling pathway implicated in the regulation of both membrane traffic and transport.
INTRODUCTION
In mammals, pigmentation of the skin, hair and eyes results
from the presence and distribution of melanins. These black-
brown and yellow-red pigments are synthesized by specialized
pigment cells, including skin melanocytes and retinal pigment
epithelium (RPE), within dedicated intracellular organelles,
named melanosomes (1). Melanosomes are commonly classi-
fied as lysosome-related organelles (2,3); however, they differ
from lysosomes and are distinct from the canonical endocytic
pathway, displaying unique structural and functional features
(4). Melanosomes are thought to originate from endosomal pre-
cursors (5) and subsequently undergo a series of maturation
stages, each characterized by typical ultrastructural morphology
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and melanin content: stage II and III correspond to non-
pigmented and partially pigmented immature melanosomes,
respectively, and stage IV to fully melanized mature orga-
nelles (6,7).
Pigmented melanosomes move from the perinuclear region
towards the cell periphery, from where they are eventually
transferred to surrounding keratinocytes in the skin. The trans-
port process is dependent both on microtubules (MTs), by
means of kinesin and dynein motors, and on actin filaments
(AFs), by means of a tripartite complex comprising the mono-
meric GTPase Rab27a, its effector melanophilin, and the
actin-based motor myosin Va in melanocytes (for review see
8), or Rab27a, MyRIP and myosin VIIa in RPE (9,10).
Studies in mammalian melanocytes and in the related fish
and frog melanophores have revealed that these two cyto-
skeletal systems regulate the distribution of melanosomes by
generating opposite and competitive forces, as in a ‘tug of
war’, in which MTs promote perinuclear accumulation and
AFs support peripheral dispersal of the organelles (11).
Accordingly, MT depolymerization or dynein down-regulation
result in centrifugal AF-dependent displacement of melano-
somes (12,13), while disruption of actin-based motility by
drugs or inactivation of the Rab27a/melanophilin/myosin Va
complex causes centripetal MT-dependent redistribution of
the organelles (8,14). Similarly, in the absence of a functional
Rab27a/MyRIP/myosin VIIa complex, melanosomes redistri-
bute from the actin-rich apical region of RPE cells to the
MT-filled cell body, indicating that melanosome movement
and distribution in the retina and skin melanocytes are regu-
lated by a conserved mechanism (15,16).
Inherited defects of melanogenesis in humans comprise a
heterogeneous group of diseases, collectively defined as albin-
ism, and characterized by variable hypopigmentation of the
skin and severe developmental defects of the eyes (17).
Ocular albinism type 1 (OA1; MIM 300500) represents the
most common form of ocular albinism and is transmitted as
an X-linked trait, with affected males exhibiting severe
reduction of visual acuity, nystagmus, strabismus, photopho-
bia, iris translucency, hypopigmentation of the retina, foveal
hypoplasia and misrouting of the optic tracts, resulting in
loss of stereoscopic vision (17). Cutaneus changes are
usually mild or absent in ocular albinism. Nevertheless, the
histopathological examination of the skin may be useful in
the diagnosis of the disease, due to the typical occurrence of
giant melanosomes (macromelanosomes) both in RPE and
skin melanocytes of affected patients, suggesting that ocular
albinism is in fact an oculocutaneus disorder of melanosome
biogenesis (18).
The protein product of the human OA1 and mouse Oa1
genes, named OA1 (also known as GPR143), is an integral
membrane glycoprotein that is exclusively expressed by melano-
cytes and RPE (19,20) and shares structural and functional
similarities with G protein-coupled receptors (GPCRs). In fact,
OA1 shows seven transmembrane domains and homologies
with members of the GPCR superfamily, including residues
highly conserved in most GPCRs, some of which are the site
of albinism-causing mutations (21–23). Furthermore, OA1
binds heterotrimeric Gi, Go and Gq proteins, as revealed by
coimmunoprecipitation and in vitro binding assays, and
co-localizes with Gi proteins in normal human melanocytes
(21). Finally, OA1 was found to interact with a yeast/mamma-
lian G protein chimera in a yeast-based signalling assay (24),
and to efficiently activate heterotrimeric G proteins and bind
the GPCR-adaptors arrestins in a mammalian expression
system, thus behaving as a bona fide GPCR (25).
However, unlike canonical GPCRs, OA1 is not localized to
the cell surface, but is exclusively detectable on the membrane
of intracellular organelles, namely late-endosomes/lysosomes
and melanosomes (19–21). In addition, we recently identified
two separate sorting signals that are both necessary and suffi-
cient for the intracellular localization of OA1 in melanocytic
and non-melanocytic cells (26). These findings support the
idea that OA1 is a resident GPCR of lysosomes and melano-
somes, and that, according with its established topological
orientation with the C-terminus towards the cytoplasm
(21,23), a putative ligand should exist within the organelle
lumen. The downstream pathway triggered by OA1 remains
mysterious and can only be hypothesized based on the pre-
sence of macromelanosomes resulting from loss-of-function
of the receptor in human patients, as well as in a mouse
model of the disorder (27), suggesting a defect in organelle
biogenesis.
Although the eyes appear more severely affected than the
skin in ocular albinism, the RPE represents a difficult
system to study melanosome biogenesis, due to the short pre-
natal time window of melanogenesis in vivo, and to the poor
melanogenic ability of cultured cells from post-natal eyes
(28). In contrast, skin melanocytes are highly and continuously
active in melanosome production both in vivo and in culture,
and melanocyte cell lines have been extensively used to
uncover pathways leading to organelle morphogenesis in
pigment cells. Therefore, in order to unravel the role of OA1
in melanosome biogenesis, we coupled the examination of
Oa1-KO RPE at early developmental stages in vivo with the
generation and analysis of Oa1-KO melanocyte cultures.
Our results indicate that OA1 regulates not only the biogen-
esis, but also the motility of melanosomes.
RESULTS
Oa1-KO RPE displays abnormal distribution of
melanosomes towards the apical surface
Our previous studies of RPE from Oa1-KO mice have
shown that the cytological abnormalities typically observed
in ocular albinism, namely reduced number and increased
size of mature melanosomes, are first observed at or after
birth (27,29). However, the anomalies of the visual system
leading to optic misrouting manifest at earlier developmental
stages (30). We reasoned that embryonic Oa1-KO RPE
might display subtle melanosomal abnormalities that remained
undetected, since extensive quantitative analyses at prenatal
stages have never been carried out. Therefore, we performed
an ultrastructural evaluation of mouse retinas collected from
wild-type and Oa1-KO mice at embryonic (E) days 15.5,
18.5 and at birth (post-natal day 0, P0). At these stages,
which precede the formation of macromelanosomes, mature
melanosomes are sufficiently abundant in both wild-type and
Oa1-KO RPE, allowing a statistically relevant comparison
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of organelle size, density and distribution. The results of this
analysis are shown in Figure 1.
At birth (Fig. 1A and B), mature melanosomes showed
comparable size in wild-type and Oa1-KO RPE, although
the latter displayed a slight increase in melanosome size (by
10%), possibly indicating that the pathological process sub-
sequently leading to the formation of the giant organelles is
already initiated (Fig. 1B). In contrast, the number of orga-
nelles per square micron was dramatically reduced in
Oa1-KO RPE (40% less than wild-type; Fig. 1B), consistent
with previous observations (29). In addition, although a
greater fraction of melanosomes was located in the apical
region compared with the basolateral side in all samples,
this displacement appeared more striking in Oa1-KO RPE
(Fig. 1A). To quantify this difference, we calculated the
percent of organelles located in the apical area in several inde-
pendent sections (see Materials and Methods). We found that,
while in wild-type RPE over half of all melanosomes were
located in the apical region, in Oa1-KO RPE this value was
increased by 20% (Fig. 1B). Results on organelle size,
density and distribution were essentially identical at E18.5,
with the percent of apical melanosomes increasing from
65% in wild-type to 82% in Oa1-KO RPE (P , 0.0001;
number of RPE sections ¼ 20; data not shown). In contrast,
the size and number of mature melanosomes were not signifi-
cantly different between wild-type and Oa1-KO RPE at E15.5.
Interestingly, even at this stage the percent of apical melano-
somes was higher in Oa1-KO than wild-type RPE (Fig. 1C),
suggesting that this abnormal organelle distribution might rep-
resent an early event in the pathogenesis of the disease.
Oa1-KO melanocytes show abnormal distribution of
melanosomes towards the cell periphery
To verify whether skin melanocytes display abnormal melano-
some distribution, as RPE cells, we generated immortalized
melanocyte cell lines from homozygous Oa1þ/þ (melan-A,
indicating wild-type agouti), heterozygous Oa1þ/2
(melan-Oa1þ/2) and homozygous Oa12/2 (melan-Oa12/2)
female mice, and initially analyzed them by bright field
optical microscopy. In fact, this approach allows the identifi-
cation of melanosomes as the only visible organelles, thanks
to the dark melanin pigment. Despite their agouti A/A geno-
type, in culture all these cells displayed pigment colour
similar to genetically black (a/a) melanocytes as expected,
since the agouti gene is not expressed by melanocytes and
the culture conditions stimulate eumelanogenesis. Relative to
Oa1þ/þ and Oa1þ/2 cells, which appeared indistinguishable
(see Materials and Methods and Supplementary Material,
Fig. S1, for cell line characterization), Oa12/2 melanocytes
showed the presence of macromelanosomes (Fig. 2A) and a
reduced density of pigmented organelles, consistent with a
lower melanin content (75–50% less than that of wild-type,
depending on passage; not shown). Larger melanosomes,
detectable in 30–50% of Oa12/2 cells, showed variable size
and were typically surrounded by apparently normal melano-
somes, although cells containing mostly giant organelles
were also observed.
Figure 1. Melanosomes are more concentrated towards the apical surface in
Oa1-KO RPE. (A) Micrographs of RPE cells from wild-type and Oa1-KO
mice at P0. At this stage, RPE apical processes (and photoreceptor outer seg-
ments) are not developed yet and therefore could not be evaluated. Dashed
lines indicate the boundaries of apical and basolateral regions of RPE cells
as defined to quantify melanosome distribution (see below and Materials
and Methods). In Oa1-KO RPE, a greater fraction of melanosomes appears
located in the apical region (this is particularly evident in areas devoid of
nuclei). Arrows, apical membrane; arrowheads, basal membrane. Bars,
1 mm. (B and C) Quantification of melanosome size, density and distribution
in wild-type and Oa1-KO RPE at P0 (B), and E15.5 (C). Melanosome size his-
tograms represent the mean+ SD of the major organelle diameter measured
for 120–140 (B) or 215–230 (C) melanosomes belonging to different sections
and with an apparent size 0.5 mm. Melanosome density histograms represent
the mean+SD of the number of organelles per mm2 obtained from 7–8 (B) or
23–25 (C) independent RPE sections. Melanosome distribution histograms
represent the mean+SD of the percent of organelles located in the apical
area (apical third of the selected area, see Materials and Methods) over the
total number of organelles in 20–25 independent RPE sections. Total
number of melanosomes counted to determine melanosome distribution:
wild-type ¼1132 (B) and 753 (C); Oa1-KO ¼ 891 (B) and 575 (C). P ,
0.02, P , 0.002, P , 0.001, P , 0.00001 (unpaired Student’s t-test
assuming equal variances). At both stages, including E15.5, when the orga-
nelles are not enlarged nor significantly reduced in number yet, melanosomes
are more abundant towards the apical region of RPE cells in Oa1-KO com-
pared with wild-type mice.
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The reduced melanosome density in Oa12/2 melanocytes
was particularly evident in the central cytoplasm, while the pig-
mented organelles appeared relatively more concentrated at the
periphery (Fig. 2A–C). The low-density region corresponded
to the perinuclear area, as shown by nuclear co-staining
(Fig. 2B), and was centred on the Golgi apparatus (Fig. 2C).
In contrast, in wild-type melanocytes, melanosomes were
evenly distributed throughout the cytoplasm, either delimiting
tightly or shielding the nuclear envelope, and were often
more concentrated around the Golgi apparatus, while the
equivalent region appeared ‘empty’ in Oa12/2 cells (Fig. 2C,
arrowheads). This distribution phenotype was observed in the
majority of Oa12/2 melanocytes and was virtually absent in
Oa1þ/þ and Oa1þ/2 cells, suggesting that it could represent
Figure 2. Melanosomes are displaced towards the cell periphery in Oa1-KO melanocytes. (A) Representative bright field optical pictures of the indicated
melanocyte cell lines, in which melanosomes, thanks to the melanin pigment, represent the only visible dark objects. In addition to the presence of larger melano-
somes (see inset for 3 magnification), Oa12/2 melanocytes show exclusion of the pigmented organelles from the perinuclear region and their concentration at
the cell periphery. (B) Melanosomes are colocalized with the cell nuclei, visualized by Hoechst staining. The merge shows poor overlap between melanosomes
and the cell nuclei in Oa12/2 cells. (C) Melanosomes are colocalized with the Golgi apparatus, visualized by anti-giantin antibodies. Arrowheads in bright field
pictures and merge point to the melanosomal enrichment in the Golgi area in Oa1þ/2, but not Oa12/2, melanocytes. Bars, 15 mm.
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a key consequence of OA1 deficiency. Finally, electron
microscopy analysis of Oa12/2 melanocytes revealed the pre-
sence of morphologically normal melanosomes at all matu-
ration stages (Fig. 3, arrows and arrowheads), together with
the occurrence of giant completely melanized organelles with
an average diameter about 3-folds larger than normal (Fig. 3,
asterisks). Overall, these findings are consistent with the
present and previous studies on Oa1-KO mouse retinas
(27,29) and confirm the suitability of the cultured mouse mela-
nocytes as in vitro model of Oa1-KO pigment cells.
The peripheral displacement of melanosomes depends on
OA1 function
In order to confirm that the melanosomal phenotype observed
in Oa12/2 cells is due to OA1 loss-of-function, we transfected
them with expression vectors for wild-type or mutant human
OA1. In transient transfections, 24 h of OA1 expression
were not sufficient to rescue the abnormal melanosomal size,
which might require organelle turnover (Fig. 4A, pR/OA1wt;
arrows). In contrast, this short expression time was sufficient
to correct the abnormal distribution of melanosomes, leading
to a concentration of pigmented organelles in the peri-
nuclear/Golgi area where OA1 is also normally enriched
(Fig. 4A, pR/OA1wt; arrowheads). Recovery of the peri-
nuclear distribution involved only a subset of melanosomes,
most often tiny and lightly pigmented and possibly newly
formed, while a conspicuous fraction of melanosomes, includ-
ing the giant ones, were not redistributed towards the cell
centre and remained at the periphery (Fig. 4A, pR/OA1wt).
As expected, no melanosome redistribution was observed
by transient expression of mutant OA1 proteins, either carrying
a missense mutation identified in patients with ocular albinism
(22) (Fig. 4A, pR/OA1T232K; arrowhead), or deleted of a criti-
cal region for GPCR activity (OA1D18, not shown; see below).
To obtain a complete phenotypic rescue, Oa12/2 melano-
cytes were stably transduced with retroviral vectors carrying
Figure 3. Both normal and giant melanosomes are found in Oa1-deficient
melanocytes. Ultrastructural analysis of the indicated cell lines, in which
mature fully pigmented melanosomes appear as black organelles due to
melanin electron density and display either elliptical or spherical shapes
depending on the section. Oa12/2LOA1SN and Oa12/2LOA1D18SN, cell
lines derived from transduction of Oa12/2 melanocytes with retroviral
vectors carrying the wild-type or mutant OA1, respectively. Similarly to wild-
type, Oa12/2 and Oa12/2LOA1D18SN melanocytes show immature (arrows)
and mature (arrowheads) melanosomes of normal size. However, differently
from wild-type, these cells also show the presence of macromelanosomes
(asterisks). Bars, 1 mm.
Figure 4. Expression of the OA1 cDNA rescues the Oa1-KO phenotype.
Oa12/2 melanocytes were transfected with a plasmid vector (A) or infected
with a retroviral vector (B) expressing either wild-type (pR/OA1wt and
LOA1SN) or mutant (pR/OA1T232K or LOA1D18SN; both these mutants
display a subcellular distribution indistinguishable from wild-type) human
OA1. Expression of the recombinant proteins was analyzed 24 h after trans-
fection (A), or following G418 selection through several passages (B), by
indirect immunofluorescence with antibodies specific to human OA1. Transi-
ent expression of wild-type OA1 is not sufficient to eliminate the giant mela-
nosomes (A, pR/OA1wt; arrows), which disappear only upon stable
transduction (B, LOA1SN). Redistribution of melanosomes towards the peri-
nuclear/Golgi area, where OA1 is also normally enriched, is induced by wild-
type OA1 both in transiently and stably transduced Oa12/2 cells (A, pR/
OA1wt, and B, LOA1SN; arrowheads). No correction of melanosomal size
or distribution was observed with mutant OA1 at any time (A, pR/
OA1T232K, and B, LOA1D18SN; arrowheads). Bars, 15 mm.
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either the wild-type human OA1 (LOA1SN), or a mutant that
carries a deletion of 18 amino acids in the third cytosolic loop
(LOA1D18SN), and that had been previously shown to lack
G-protein activation abilities, despite an apparently normal
subcellular distribution (25). The resulting Oa12/2LOA1SN
and Oa12/2LOA1D18SN melanocyte lines showed stable
OA1 expression in 80–90% of cells by immunofluorescence
analysis (not shown). Optical and electron microscopy exam-
ination revealed that in Oa12/2LOA1SN cells the size of
melanosomes was homogeneous and comparable to Oa1þ/2
melanocytes (Figs 3 and 4B). In addition, the organelles recov-
ered to an even cytoplasmic distribution with increased
concentration in the perinuclear/Golgi region (Fig. 4B, arrow-
heads). In contrast, no rescue of macromelanosomal pheno-
type and abnormal melanosomal distribution was observed
in Oa12/2LOA1D18SN melanocytes (Figs 3 and 4B).
Finally, the requirement for OA1 in normal melanosome dis-
tribution was further confirmed by RNA interference (RNAi)
studies, which reproduced the Oa1-KO phenotype in
Oa1þ/2 melanocytes (data not shown).
Oa1-KO melanocytes behave similarly to wild-type upon
disruption of AF-based transport
All together, the above findings indicate that both in RPE cells
and skin melanocytes the absence of OA1 function determines
an alteration of melanosome distribution that appears opposite
to that observed upon disruption of AF-mediated transport and
suggests a dysfunction in melanosome motility along MTs
and/or AFs. In both parental Oa1þ/2 and Oa12/2 melano-
cytes, as well as transduced Oa12/2LOA1SN and Oa12/2
LOA1D18SN cells, the MT cytoskeleton displays a similar
radial arrangement, with the greatest concentration of tubulin
filaments in the perinuclear region (Fig. 5A and Supplemen-
tary Material, Fig. S2). This organization appears in striking
contrast with the distribution of melanosomes, which are
enriched at the centrosome in wild-type cells, while are
excluded from this area in Oa1-deficient melanocytes
(Fig. 5A, arrowheads). Conversely, in all cell types AF stain-
ing is more prominent at the cell periphery (Fig. 5A and Sup-
plementary Material, Fig. S2), as previously reported (31),
Figure 5. Melanosomes redistribute according to MT density towards the nucleus upon disruption of the actin network in wild-type and Oa1-KO melanocytes.
(A) Melanosome distribution and cytoskeletal organization. Pictures show the typical distribution of melanosomes, visualized in bright field, compared with
tubulin or actin filaments, visualized by indirect immunofluorescence with anti-tubulin antibodies or phalloidin staining, respectively, in Oa1þ/2 and
Oa12/2 cells. Black/white circles indicate the perinuclear area, as defined in organelle tracking analyses (see Materials and Methods), which is typically
enriched in MTs (and melanosomes in wild-type, but not mutant, cells), while AF are more abundant at the cell periphery. Arrowheads point to the position
of the centrosome. In Oa12/2 melanocytes, despite a similar cytoskeletal organization, melanosomes appear excluded from the MT-enriched perinuclear
region. (B) Melanosome redistribution upon disruption of the actin cytoskeleton. Shown are representative bright field pictures of Oa1þ/2 and Oa12/2 cells
prior to treatment (untreated); after 1 h of cytochalasin D treatment (cyto D 1 h); and, following removal of the drug and extensive washing, allowed to
recover for 1 h (recovery 1 h). In both cell types, melanosome similarly redistribute upon AF disruption and recover to the original distribution after withdrawal
of the drug. (C) Melanosome redistribution after 1 h of cytochalasin D treatment is compared with the residual AF labelling by phalloidin under the plasma
membrane, confirming the absence of generalized retraction of cell margins. Bars, 15 mm.
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suggesting that abnormal melanosome distribution is not a
consequence of cytoskeletal disorganization.
To test whether the Oa1-KO phenotype is due to inability of
melanosomes to move on tubulin filaments, we eliminated the
contribution of actin-based transport by using AF-disrupting
drugs. Treatment with cytochalasin D (which caps AFs indu-
cing reorganization of the actin cytoskeleton in short actin
patches; see Supplementary Material, Fig. S2) resulted in a
similar perinuclear concentration of melanosomes both in
wild-type and Oa1-deficient cells, either parental or trans-
duced, with rapid recovery (within 1 h) of the initial distri-
bution upon drug withdrawal (Fig. 5B and data not shown).
Similar results were obtained with latrunculin A, although
higher cell toxicity was observed (not shown). As alternative
approach, we inhibited actin-based transport by transfecting
wild-type and Oa1-deficient melanocytes with a plasmid
encoding a dominant-negative construct for myosin Va, con-
sisting in the melanocyte-specific tail domain of the motor
(pEGFP-MC-LT) (31). Constructs for EGFP alone or the
brain-specific tail domain of myosin Va (pEGFP-BR-LT)
(32) were used as negative controls. Following 24–72 h of
expression, pEGFP-MC-LT was able to induce a striking peri-
nuclear distribution of melanosomes in both wild-type and
Oa1-deficient cells (Fig. 6A and Supplementary Material,
Fig. S3A), reminiscent of the dilute phenotype (null at the
Myo5a gene locus). In contrast, no or minor effects were gen-
erated by pEGFP or pEGFP-BR-LT, consistent with previous
observations (32). Quantification of the dilute-like phenotype
in pEGFP-MC-LT expressing cells revealed a comparable
behaviour of wild-type and Oa1-deficient cell lines, either par-
ental or transduced (Fig. 6B), supporting the notion that lack
of OA1 function does not impair MT-based motility per se.
The behaviour of wild-type and Oa1-deficient melanocytes
also suggested that myosin Va was similarly recruited to
Figure 6.Melanosomes aggregate to the central cytoplasm upon disruption of myosin Va function and efficiently recruit its tail domain in wild-type and Oa1-KO
melanocytes. (A) Representative optical pictures showing the redistribution of melanosomes upon expression of a dominant-negative construct for myosin Va.
Oa1þ/2 and Oa12/2 cells were transfected with pEGFP-MC-LT, driving the expression of the EGFP-tagged melanocyte-specific tail domain of myosin Va. The
pEGFP-BR-LT plasmid, driving the expression of the brain-specific tail domain of myosin Va, was used as negative control. After 24–72 h, the distribution of
melanosomes in bright field was assessed in EGFP-positive cells. The white line marks the edges of transfected cells. Bars, 15 mm. (B) Quantification of melano-
some aggregation in parental and transduced pEGFP-MC-LT transfected cells. Results represent the mean + SD of 2-3 independent experiments (total number
of cells counted for each line: 80–250). The dilute-like phenotype was observed in a similarly high percent of transfected wild-type and Oa1-deficient melano-
cytes. (C) Representative optical pictures showing the colocalization of melanosomes with the melanocyte-specific tail domain of myosin Va. Oa1þ/2 and
Oa12/2 cells were transfected with pEGFP-MC-LT and analyzed before the appearance of a complete dilute-like phenotype. Melanosomes are typically sur-
rounded by a ring of fluorescence corresponding to the EGFP-MC-LT construct in both wild-type and Oa1-KO cells. In the insets (4 magnification), arrows
point to examples of colocalization. Bars, 15 mm. (D) Quantification of melanosome colocalization with the EGFP-MC-LT fusion protein in parental and trans-
duced transfected cells. Results represent the mean + SD of the data obtained from 10 different cells pooled from 2–3 independent experiments (total number of
melanosomes counted for each cell line: 250–300). No significant differences were found between wild-type and Oa1-deficient melanocytes.
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melanosomes in both cell types. To directly confirm this
expectation, we performed co-localization studies in cells
transfected with pEGFP-MC-LT before the appearance of a
completely aggregated phenotype. As shown in Figure 6C
and Supplementary Material, Figure S3B, we observed that
the EGFP-MC-LT fusion protein distributed in a ring-like
pattern in most transfected cells and was found to label a
high fraction of melanosomes in both Oa1þ/2 and Oa12/2
melanocytes (Fig. 6C), as well as Oa12/2LOA1SN and
Oa12/2LOA1D18SN melanocytes (Supplementary Material,
Fig. S3B). Quantification of co-localization in different trans-
fected cells revealed an identical fraction of mature melano-
somes positive for EGFP-MC-LT in wild-type and
Oa1-deficient cell lines, either parental or transduced
(Fig. 6D). In addition, consistent with the observation that
all melanosomes, independently on their size (Fig. 6A and
Supplementary Material, Fig. S3A; Fig. 7), were redistributed
towards the nucleus upon pEGFP-MC-LT transfection in
Oa1-deficient melanocytes, both normal and giant melano-
somes were found to extensively co-localize with the fusion
protein (Fig. 6C and Supplementary Material, Fig. S3B).
These data suggest the presence of an intact binding site for
myosin Va on Oa1-KO melanosomes and do not support the
possibility that lack of OA1 function grossly interferes with
the correct recruitment of the Rab27a/melanophilin/myosin
Va tripartite complex on the organelles.
Oa1-KO melanocytes exhibit reduced melanosome motility
in the presence of intact AF-based transport
The depletion of melanosomes from the MT-enriched peri-
nuclear region and their relative concentration in the
AF-enriched cell periphery in Oa1-KO melanocytes suggest
a defect of MT or a prevalence of AF-based transport.
However, Oa1-deficient melanosomes are able to efficiently
move on MTs towards the nucleus upon AF removal and
show a similar capacity of recruiting the myosin Va tail
domain compared with organelles in wild-type cells. To deter-
mine whether melanosomes do actually display abnormal
motility in the absence of OA1, we performed time-lapse
video microscopy in living cells. In order to reduce the inci-
dence of cell line-dependent variables, we compared both par-
ental Oa1þ/þ and Oa1þ/2 versus Oa12/2 lines, and
transduced Oa12/2LOA1SN versus Oa12/2LOA1D18SN
lines. Bright field movies were obtained by capturing two pic-
tures per second for 90 s from melanocytes, either untreated or
following treatment with AF- or MT-disrupting drugs, or fol-
lowing transfection with pEGFP-MC-LT.
The direct observation of movies acquired in untreated con-
ditions revealed that in general melanosomes display variable
and intermittent motility, with slow movements and pauses
interrupted by bursts of faster movements, as described pre-
viously (9,31). Moreover, both in Oa1þ/2 (or Oa1þ/þ) and
Oa12/2 melanocytes, melanosomes within a few microns
from the nucleus were more motile than those towards the
cell periphery (Fig. 7 and Supplementary Material, Movies
1–4). This distinction presumably depends on the different
distribution of MTs, concentrated in the central cytoplasm
and responsible for fast long-range bidirectional movements,
relative to AFs, predominant at the cell periphery and respon-
sible for local short-range movements (7,33). However, in
wild-type melanocytes the organelles showed a definitively
higher motility compared with Oa1-KO cells, particularly in
the perinuclear region, but also towards the periphery (Fig. 7
and Supplementary Material, Movies 1–4). Nocodazole treat-
ment lead to a general paralysis of melanosome movements in
Figure 7.Melanosomes display defective motility in Oa1-KO melanocytes. Representative examples of melanosome paths covered during the 90 s time frame in
Oa1þ/2 and Oa12/2 cells, either in untreated conditions (NT), or after nocodazole treatment, or following expression of the dominant-negative myosin Va
construct (EGFP-MC-LT). In untreated cells, melanosomes were analysed either within (NT in), or outside (NT out) of the perinuclear area, which is delimited
by the black 15 mm-radius circle in the pictures. In the insets (2.5 magnification) representative trajectories are shown in red. The longest paths occur in
untreated Oa1þ/2 cells (particularly in the perinuclear area) and in pEGFP-MC-LT-transfected Oa1þ/2 and Oa12/2 cells, while melanosomes appear
mostly stationary in untreated Oa12/2 cells and in both cell types upon nocodazole treatment. Bars, 5 mm.
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all cell lines (Fig. 7), suggesting that most appreciable move-
ments are in fact MT-dependent. Conversely, pEGFP-MC-LT
transfection or cytochalasin D treatment resulted into a simi-
larly intense organelle motility throughout the cytoplasm in
both wild-type and Oa1-KO cells (Fig. 7, Supplementary
Material, Movies 5 and 6, and not shown). Similar results
were obtained in transduced cell lines (not shown).
To quantify these observations, we performed organelle
tracking studies. Given the gradient of motility from the
central region to the periphery of cells in untreated conditions,
we made a distinction between the organelles localized close to
the nucleus and those at some distance (Fig. 7; see Materials and
Methods for further details). In addition, since Oa12/2 and
Oa12/2LOA1D18SN melanocytes often display a considerable
heterogeneity inmelanosome dimensions, and this physical vari-
able could influence organelle motility, we compared melano-
somes of equivalent size in wild-type versus Oa1-deficient
lines (Supplementary Material, Fig. S4 and Table S1; see
Materials and Methods for further details). Figure 8 shows the
quantification of results obtained in various conditions. To
define the characteristics of MT and AF-dependent movements
in our system, we first pooled all melanosome steps obtained
from Oa1þ/2 melanocytes, either untreated or following
various treatments, and binned them in three increasing speed
intervals: 0.0–0.2, 0.2–0.4 and 0.4mm/s (Fig. 8A, white,
light grey and dark grey bars, respectively).
In untreated Oa1þ/2 melanocytes, organelle tracking within
the perinuclear area (Fig. 8A, NT in) resulted in 55% of steps
corresponding to pauses or slow movements under 0.2 mm/s,
38% of steps corresponding to movements between 0.2 and
0.4 mm/s, and the remaining 7% of steps corresponding to
faster movements. Consistent with a progressive depletion of
MTs towards the cell periphery, organelle tracking outside
the perinuclear area (Fig. 8A, NT out) resulted in a reduction
of melanosome motility, which was further decreased upon
nocodazole treatment (Fig. 8A, Nocodazole). In the latter con-
dition, we observed an almost complete disappearance of steps
corresponding to fast speeds 0.4 mm/s, suggesting that they
actually reflect true MT-dependent motility. In contrast, in
pEGFP-MC-LT-transfected or cytochalasin D-treated
Oa1þ/2 cells, melanosome motility was recovered to values
similar to that displayed by perinuclear organelles in untreated
melanocytes (Fig. 8A, EGFP-MC-LT and Cyto D). When
Oa12/2 melanocytes were subjected to similar analysis, an
overall lower motility of melanosomes was observed in
untreated conditions. In fact, the values obtained within (NT
in) and outside (NT out) the perinuclear area in Oa12/2
cells were closely resembling those found outside the peri-
nuclear area (NT out) and upon nocodazole treatment in
Oa1þ/2 cells, respectively. However, when AF-based trans-
port was disrupted by pEGFP-MC-LT transfection or cytocha-
lasin D treatment, melanosomes in Oa12/2 melanocytes
Figure 8. Quantification of melanosome motility in wild-type and Oa1-KO melanocytes. (A) Speed distribution profile obtained by pooling and binning in
increasing speed intervals, as indicated, all melanosome steps from Oa1þ/2 melanocytes, or from Oa12/2 melanocytes. Cells were analyzed either untreated
and selected inside or outside of the perinuclear area (NT in and out, respectively); or after treatment with nocodazole to deplete the MTs; or following
expression of the dominant-negative myosin Va construct (EGFP-MC-LT), or treatment with cytochalasin D (Cyto D) to disrupt AF-based transport.
Number of melanosomes tracked: NT in ¼ 103, NT out ¼ 100, nocodazole ¼ 90, EGFP-MC-LT and Cyto D ¼ 50 (obtained from several different cells:
10–12 for NT and nocodazole; 5–7 for EGFP-MC-LT and Cyto D). Data are expressed as percent of total steps. In both melanocyte lines, speeds 0.4
mm/s (dark grey) are totally abolished by nocodazole, indicating that they represent a pure MT-dependent component. Oa12/2 melanocytes show a decreased
motility in untreated conditions, yet recover completely upon disruption of AF-based transport. (B) Average total path of melanosomes from the same tracking
analysis described above for Oa1þ/2 versus Oa12/2 melanocytes, and from similar analyses performed in Oa1þ/þ versus Oa12/2 melanocytes, and in trans-
duced Oa12/2LOA1SN versus Oa12/2LOA1D18SN lines. For each wild-type and Oa1-deficient lines compared in the graphs, tracked melanosomes were of
comparable size (see Supplementary Material, Table S1). Results represent the mean+SEM of the data from 40–100 melanosomes (considering one melano-
some path as one data point). Compared with their wild-type counterpart, Oa1-deficient melanocytes show a significantly reduced average displacement in
untreated conditions, while they completely recover upon pEGFP-MC-LT transfection, or cytochalasin D treatment. Transduced lines showed poor motility
at the cell periphery (possibly due to the drug treatment necessary for maintenance of the transgenes), so differences were only appreciable in the perinuclear
area. P, 0.004, P, 0.00001 (unpaired Student’s t-test assuming equal variances).
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completely recovered their motility to levels comparable to
organelles in wild-type cells. Similar results were obtained
in Oa12/2LOA1SN versus Oa12/2LOA1D18SN cells and
in untreated Oa1þ/þ versus Oa12/2 melanocytes (not
shown; analysis of Oa1þ/þ melanocytes upon transfection or
drug treatment was not possible due to cell suffering).
To determine the significance of these findings, we calculated
the total paths covered by single melanosomes. Melanosome
values for each wild-type line were averaged and compared
with those obtained from the respective Oa1-deficient counter-
part (Fig. 8B). In untreated conditions, Oa12/2 and Oa12/2
LOA1D18SN melanocytes showed a profound and significant
reduction of melanosome motility compared with their wild-
type counterparts. These differences could mainly be attributed
to MT-based transport, since (i) the higher motility of wild-type
melanosomes was easier to appreciate in the MT-enriched peri-
nuclear region (Figs 7 and 8B, compare melanosome paths in
untreated conditions in Oa1þ/2 versus Oa12/2 cells and in
transduced lines); (ii) fastest movements 0.4 mm/s, reflecting
MT-dependent motility, were more represented in wild-type
than Oa1-deficient melanocytes (Fig. 8A) and (iii) the contri-
bution of AFs to melanosome paths appeared negligible, since
the average displacement calculated upon nocodazole treatment
was 1.5–3.0 mm/90 s in all cell lines (not shown).
When the same analysis was conducted considering only
melanosomes showing fast movements (0.4 mm/s), which
represent a greater fraction in wild-type (54–91%, depending
on cell line and distance from nucleus) than Oa1-deficient mel-
anocytes (16–61%), differences were partially levelled (data
not shown). These findings suggest that the main defect in
Oa1-deficient melanocytes consists in a lower frequency
(rather than velocity) of MT-based movements. However, in
the absence of actin-based transport, Oa1-deficient melano-
somes not only redistributed at the cell centre as in wild-type
cells, but also showed equivalent motility on MTs. In fact,
upon pEGFP-MC-LT transfection or cytochalasin D treatment
differences were basically abolished, with melanosomes in
Oa1-deficient cells showing a recovery of motility equivalent
to that observed in the perinuclear area of wild-type cells
(Fig. 8B). Finally, we evaluated whetherOa1-deficient melano-
somes move towards the cell centre or the periphery at different
rates compared with wild-type organelles. The ratio between
centrifugal and centripetal displacement was determined for
single melanosomes and values for each wild-type line were
averaged and compared with those obtained from the respective
Oa1-deficient counterpart. No significant differences were
found between wild-type and Oa1-deficient cells, either at
steady-state or following AF disruption (Supplementary
Material, Fig. S5), suggesting that OA1 might not affect the
balance between kinesin and dynein motors. From these data
we conclude that in the absence of OA1 function melanosomes
move less efficiently and especially less frequently on the
tubulin cytoskeleton, however, this deficiency is not intrinsic
of the MT-based transport system and manifests exclusively
in the presence of intact actin-based transport.
DISCUSSION
The histological hallmark of ocular albinism is the presence of
macromelanosomes in pigment cells of the skin and eyes,
suggesting a defect in melanosome biogenesis. However, the
process leading to macromelanosome formation and the
actual role of the giant organelles in the pathogenesis of
the disease remain unclear. In fact, the macromelanosomal phe-
notype displays variable expressivity in vitro and in vivo (34,35)
and, at least in the mouse, manifests during development sub-
sequent to optic misrouting, implying that it might represent
only an epiphenomenon of the disease (27). In the search for
the primary role of OA1 in ocular albinism, we identified an
abnormally skewed distribution of melanosomes towards the
apical pole of the RPE inOa1-KOmice at embryonic stages pre-
ceding the formation of macromelanosomes and the reduction
of organelle number. An equivalent abnormality was replicated
in melanocyte cultures obtained from the skin ofOa1-KOmice.
In fact, Oa1-KO melanocytes showed not only abnormal size,
but also abnormal distribution melanosomes, with depletion
of the organelles from the perinuclear area and accumulation
towards the cell periphery. Despite their exclusion from the
central cytoplasm at steady-state, Oa1-KO melanosomes were
able to aggregate at the centrosome upon disruption of the
actin cytoskeleton or expression of a dominant-negative con-
struct for myosin Va. Finally, melanosome tracking analyses
revealed a significant reduction of MT-based motility exclu-
sively in the presence of intact AF-mediated transport, consist-
ent with the idea that OA1 might regulate the dynamic
equilibrium between the two cytoskeletal systems. These
results were independent on the physical size of melanosomes,
thus revealing a novel function for OA1 in organelle transport
that might be of relevance for the disease pathogenesis.
OA1 regulates melanosome transport on MTs
Both in melanophores and mammalian melanocytes, the distri-
bution of melanosomes results from the dynamic balance
between AF-based and MT-based transport. In fish or frog
melanophores, the switch between these two transport
systems is believed to depend on signalling events, including
cAMP and protein kinases, that direct the coordinated dis-
persion or aggregation of melanosomes in response to extra-
cellular stimuli and result in colour adaptation (for review
see 36). In contrast, in mammalian melanocytes, melanosome
transport is associated with melanogenesis and is thought to
proceed mostly in a perinuclear to centrifugal route, adapted
to ensure the peripheral accumulation of mature melanosomes
prior to keratinocyte transfer (7). In this context, locally oper-
ating signalling mechanisms would allow the organelles to
move independently of one another, perhaps depending on
their maturation stage. The observation that not all melano-
somes are redistributed in Oa12/2 cells upon transient
expression of OA1 (Fig. 4A) suggests that OA1 does not func-
tion through diffuse cytosolic signalling, but rather in an orga-
nelle autonomous fashion.
In the competition between the actin and tubulin cyto-
skeletal systems, OA1 seems to facilitate the functional inter-
action of pigmented melanosomes with MTs, which could
determine by itself the accumulation of organelles in the peri-
nuclear area. In fact, when actin-mediated capture at the cell
periphery is down-regulated, melanosomes typically redistri-
bute according to MT density and therefore in the central cyto-
plasm where the bulk of tubulin filaments reside (31). Based
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on our data and because of the ‘tug of war’ between the two
transport systems involved, we cannot distinguish if stimulation
of MT-based transport is a direct effect of OA1 activity, or the
indirect result of inhibition of actin-based transport. OA1 might
act by tethering melanosomes to tubulin filaments, thereby sta-
bilizing the productive association between cargo and cyto-
skeletal route, as hypothesized for the dynactin complex (37).
Alternatively, OA1 could counteract the capture of melano-
somes by the AF system and as a consequence enhance the
frequency by which the organelles move along MTs (11,31),
while in the absence of OA1 melanosome entrapment by the
actin network at the cell periphery would prevail.
The exact molecular mechanism by which OA1 accom-
plishes its effects on transport remains unclear. Our analyses
indicate a normal ability of Oa1-KO melanosomes not only
to move on MTs, but apparently also to recruit the Rab27a/
melanophilin/myosin Va tripartite complex responsible for
actin-mediated capture, suggesting that the receptor might
play a regulatory—rather than structural—role in the con-
certed effort of MT and AF-based motors required for
proper organelle distribution. Switching between MT and
AF-based systems is regulated by cytoplasmic cAMP levels
in fish and frog melanophores (38,39). Furthermore, in the
same animal models, melanosome-associated MAP kinase
has been shown to regulate organelle transport on MTs (40).
Since OA1 appears to couple with Gai in melanocytes (21),
it is possible that it regulates the local concentration of the
second messenger, thereby using an equivalent signalling
mechanism at the single organelle level. Alternatively, OA1
might contribute to the recruitment of signalling complexes
on the melanosomal membrane, including specific adaptors
or kinases involved in transport. Consistent with the in vivo
motility studies, we found that OA1 interacts efficiently with
tubulin in co-immunoprecipitation assays (M.V.S. and P.B.,
unpublished observations), suggesting that MTs represent a
downstream effector of the receptor. However, the same
immunoprecipitates did not contain any molecular motors or
regulators known to direct the movement of melanosomes
along MTs, such as dynectin, dynein and conventional
kinesin (M.V.S. and P.B., unpublished data). Therefore, the
role of this interaction in melanosome motility remains to be
established, and further studies will be necessary to define
the signal transduction pathway triggered by OA1 and its
downstream effectors at the melanosomal membranes.
OA1 plays a role in both melanosome biogenesis and
transport
Organelle biogenesis and transport are tightly interconnected
processes (for review see 41,42) and the same protein regula-
tors, as the Rab GTPases, can control both pathways through
the assembly of multiprotein complexes on specific subcellular
compartments (43,44). Our findings with the intracellular
GPCR OA1 now add another class of GTPases to the list of
regulators of organelle biogenesis and transport, namely
heterotrimeric G proteins, which are best known as plasma
membrane transducers, but have also been implicated in
various membrane trafficking events in the endomembrane
system (45). Does OA1 regulate melanosome biogenesis and
transport independently, or one as consequence of the other?
The abnormal melanosome distribution in Oa1-KO RPE at
stages preceding the appearance of giant organelles and the
defective motility of normal size melanosomes in Oa1-KO
melanocytes, as well as the apparently normal ability of
Oa1-deficient melanosomes to recruit the myosin Va tail
domain—suggesting proper enrolment of the overall tripartite
complex on fully mature organelles—imply that regulation of
melanosome transport might represent an independent role
played by OA1 in pigment cells. Nevertheless, given the
lack of morphogenetic defects at immature melanosomal
stages and the variability of the macromelanosomal pheno-
type, it is also possible that the primary defect in ocular albin-
ism lies in organelle motility, which secondarily leads to
aberrant biogenesis. For instance, as a melanosomal GPCR,
OA1 might be sensitive to the maturation stage of the orga-
nelles and transduce this information to the cytosol by trigger-
ing a signalling cascade to retain pigmented, yet incompletely
developed, organelles on MTs for full maturation. In the
absence of OA1, melanosomes might be prematurely
transported to the cell periphery and become susceptible to
abnormal fusion events, giving rise to macromelanosomes,
especially in cells highly active in membrane remodelling
and disposal such as the RPE (46).
OA1 shares genomic localization and functional features
with SHROOM2/APXL
A combined defect in melanosome distribution and maturation,
somewhat reminiscent of OA1 loss-of-function, has been
recently reported in the RPE of Xenopus embryos lacking
SHROOM2/APXL function (47), supporting the idea that mela-
nosome biogenesis and transport are tightly bound processes.
Interestingly, the human ortholog of the SHROOM2/APXL
gene, like the OA1 gene, was originally isolated by our group
from the ocular albinism type 1 critical region on the distal
short arm of the X-chromosome (48). The involvement of
SHROOM2/APXL in ocular albinism appears unlikely, given
that most patients carry mutations within the OA1 gene
(34,49), while none was identified in SHROOM2/APXL (48).
It is nevertheless surprising that a gene possibly implicated in
the same pathways as OA1 localizes close to the OA1 gene
not only in humans (where the two genes lie 20 kb apart and
are transcribed in opposite directions; MVS, unpublished obser-
vations), but also mice (50) and even frogs (47). Whether a
related function in RPE physiology is also paralleled by a
common transcriptional regulation will be an interesting
matter for future investigations.
MATERIALS AND METHODS
Melanocyte line generation and culture
Melanocyte lines were established from Oa1þ/þ, Oa1þ/2 and
Oa12/2 female mice of the 129/Sv strain (27) and named
melan-A (designating the agouti A/A genotype),
melan-Oa1þ/2 and melan-Oa12/2, respectively. Trunk skins
from neonatal mice and mitomycin C-treated XB2 feeder
cells were used for establishment of melanocyte cell lines, as
described previously (51). Melanocytes were cultured in
RPMI 1640 (Invitrogen) supplemented with 10% foetal
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bovine serum (Sigma), 2 mM glutamine (Invitrogen), 100 U/ml
penicillin G (Invitrogen), 1000 U/ml streptomycin (Invitrogen),
200 nM tetradecanoyl phorbol-13-acetate (Sigma) and 200 pM
cholera toxin (Sigma), at 378C with 10% CO2. Cells were
used for experiments up to passage 30 (10 for subclones).
Relative to Oa1þ/2 and Oa1þ/þ cells, Oa12/2 melanocytes
displayed a quite dendritic morphology, which became particu-
larly evident in the presence of cholera toxin. This phenotype
was not corrected by transduction with wild-type OA1 (the
cell morphology of transduced Oa12/2LOA1SN and Oa12/2
LOA1D18SN melanocytes was comparable with parental
Oa12/2 cells, see below), therefore a role of OA1 in dendrite
formation remains to be established. However, to reduce mor-
phological differences, cholera toxin was used exclusively
during generation of the lines, whereas it was subsequently
omitted for their analysis. Oa1þ/þ and Oa1þ/2 melanocytes
were indistinguishable based on melanosome size and distri-
bution. Nevertheless, since Oa1, like human OA1, is located
on the X-chromosome (52–54) and might be subjected to X-
inactivation, we looked for the presence of mosaic Oa1
expression within theOa1þ/2 cell line [due to the immortaliza-
tion procedure, see (51), these melanocyte lines are expected to
originate from multiple clones]. Subclones generated by limit-
ing dilution were tested for melanosomal abnormalities and
Oa1 expression by RT–PCR (see below). All nine clones ana-
lyzed were comparable to the parental line for cell morphology
and melanosomal phenotype (Supplementary Material,
Fig. S1A) and were able to express full-length Oa1 (Sup-
plementary Material, Fig. S1B), suggesting that even if Oa1
is subjected to X-inactivation, the Oa1þ/2 cell line derives
from one or more precursors carrying the mutant X-
chromosome inactivated. Thus, we routinely used the Oa1þ/2
line as wild-type control, since in our hands these cells were
morphologically more homogeneous and showed a more
stable pigmentation through passages and freezing–thawing
cycles than Oa1þ/þ cells. However, experiments were con-
firmed with Oa1þ/þ cells and procedures involving a limited
number of cells (as melanosome tracking) were performed on
the PCR-tested Oa1þ/2 subclone #5 (Supplementary Material,
Fig. S1). Cytoskeletal drug treatments were performed as
follows: 1 mM cytochalasin D (Sigma) for 30–60 min at 378C
(after 15 min of treatment, the reorganization of AFs in short
patches was already visible and melanosomes began to redistri-
bute; over 90 min, cells often showed morphological changes,
becoming smaller and dendritic); 0.5 mM latrunculin A
(Sigma) for 10–40 min at 378C (even after 10 min, cells
showed morphological changes, becoming smaller and dendri-
tic); 30 mM nocodazole (Sigma) for 30–60 min at 378C. Disrup-
tion of cytoskeletal networks was tested by anti-tubulin
antibodies and phalloidin staining. In all treatments, only the
target cytoskeletal system was affected (Supplementary
Material, Fig. S2 and not shown).
Reverse transcription polymerase chain reaction
Cytoplasmic RNA was isolated with RNeasy Mini kit
(Qiagen), and reverse transcribed with oligo(dT) primers
using the SuperScript First-Strand Synthesis System for
RT–PCR kit (Invitrogen), according to manufacturers’
instructions. The resulting cDNA was used as template for
conventional RT–PCR reactions with primers FowmOa1-1:
50-CCACTGCCTGTGACTTGCTTG-30 and RevmOa1-9:
50-CCTGGGCTTGGGAAATGGAGT-30, which amplify a
986-bp product spanning all nine exons of the Oa1 gene.
PCR conditions were 1 cycle at 948C for 5 min, 608C for
2 min and 728C for 5 min, followed by 40 cycles at 948C
for 1 min, 628C for 1 min and 728C for 5 min in the presence
of 5% DMSO.
Expression vectors, transfection and retroviral infection
Constructs pR/OA1wt, pR/OA1T232K, LOA1SN and
LOA1D18SN, containing the wild-type and mutant OA1
cDNAs, were previously described (22,35). Plasmids
pEGFP-MC-LT and pEGFP-BR-LT were kindly provided by
Dr J.A. Hammer III (31,32) and plasmid pEGFP-Rab27a
was kindly provided by Dr M.C. Seabra (55). For transient
transfections, melanocytes were plated on 13-mm glass
coverslips, transfected using FuGENE 6 according to the
manufacturer’s instructions (Roche) and analysed 24–72 h
post-transfection. For stable transduction, retroviruses were
produced in Phoenix Eco packaging cells, following the
Nolan Lab protocol (http://www.stanford.edu/group/nolan/
protocols/pro_helper_dep.html). Phoenix cells were trans-
fected at 70% of confluence with LOA1SN and
LOA1D18SN retroviral vectors using FuGENE 6 in a 10-cm
plate. Twenty-four hours after transfection, the medium was
changed and the retroviral supernatant collected after
additional 24 h. After centrifugation and filtration to eliminate
cell debris, the retroviral supernatant was either frozen at
2808C or supplemented with polybrene (Sigma) at 8 mg/ml
and used for melanocyte infection. The day before infection,
melanocytes were seeded in 6-cm plates at 30–40% of conflu-
ence and the following day incubated with 4 ml of retroviral
supernatant/polybrene mix for 4 h. Seventy-two hours post-
infection, cells were selected as a polyclonal population with
700 mg/ml of G418 (Sigma), which was maintained thereafter
in order to avoid loss of retroviral integration.
Immunofluorescence analysis
Immunofluorescence analysis was performed as previously
described (26), using the following primary antibodies: W7
anti-OA1, rabbit anti-human OA1 polyclonal antiserum (19);
anti-b-tubulin, mouse anti-b-tubulin monoclonal antibody
(Boheringer); anti-giantin, rabbit anti-giantin polyclonal anti-
serum (a gift of Dr A. De Matteis). Secondary antibodies
were Cy3/Cy2-conjugated donkey anti-rabbit IgG and
donkey anti-mouse IgG (Jackons ImmunoResearch Labora-
tories). For staining of AFs, rhodamine (TRITC)-conjugated
phalloidin (Sigma) was used. For nuclear staining, Hoechst
33342 (Sigma) at 100 ng/ml was used for 5 min prior to
mounting. Coverslips were mounted using Mowiol 4–88
reagent (Calbiochem) and viewed with a PlanApochromat
63 n.a. 1.4 oil objective on an epifluorescence Axiophot
microscope (Zeiss). Images were acquired with a C4742-95
CCD camera (Hamamatsu Photonics) using HiPic32 software
(Hamamatsu Photonics) and processed with Photoshop
(Adobe). pEGFP-MC-LT-transfected cells typically showed
a punctuated and ring-like staining superimposed to a diffuse
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signal. At short expression times (24 h), the ring-like staining
was often spread all over the cell and was clearly surrounding
black melanosomes, whereas at longer expression times most
of the staining was concentrated in the perinuclear region
together with black melanosomes. Conversely, pEGFP-
BR-LT-transfected cells displayed at any time a punctuated
staining superimposed to a diffuse signal, with an evident
accumulation of fluorescence at the MT organizing centre
and only occasional co-localization with black melanosomes,
as described previously (32). Quantification of melanosome
redistribution following pEGFP-MC-LT transfection was per-
formed by calculating in each experiment the percent of trans-
fected cells (visualized by means of the EGFP fluorescence),
showing a dilute-like phenotype (pronounced accumulation
of melanosomes in the central cytoplasm). A small percent
of cells with an abnormally round or dendritic morphology,
indicating cell suffering, was excluded from the counts.
Since melanosome aggregation can sometimes result from
transfection-dependent cell suffering (5% of Oa1þ/2 cells
transfected with pEGFP-BR-LT or pEGFP alone showed
a dilute-like phenotype), normalization for pEGFP-
MC-LT-specific effects was obtained by subtracting in each
experiment the percent of aggregation observed in twin cover-
slips transfected with the brain-specific pEGFP-BR-LT con-
struct. Quantitative immunofluorescence analysis of the
co-localization between the EGFP-MC-LT fusion protein
and pigment granules was performed on digital micrographs
of cells displaying a bright ring-like pattern of the fusion
protein, before the appearance of a full dilute-like phenotype
(typically 24 h of expression). Distinct black melanosomes
(15–30) were randomly marked throughout the cytoplasm of
individual cells, with the exception of areas overcrowded
with organelles (perinuclear areas, tips of dendrites, areas
under the plasma membrane), and their co-localization with
EGFP-MC-LT was assessed. EGFP-MC-LT staining was con-
sidered as co-localizing with melanosomes when (i) forming a
complete or partial ring surrounding single melanosomes, and
(ii) appearing as a clear and distinct spot superimposed to iso-
lated melanosomes. More selective co-localization criteria, i.e.
considering only the ring-like pattern of EGFP-MC-LT stain-
ing, led to a reduction in the co-localization percentage (45–
50%), however, no differences were found between wild-type
and Oa1-deficient cells. In addition, although in these counts
both giant and normal size melanosomes were considered,
exclusion of the giant organelles did not lead to differences
between wild-type and Oa1-deficient cells. Statistical analyses
were performed using Microsoft Excel software.
Live cell imaging
Mouse melanocytes grown on 24-mm glass coverslips were
transferred to round adaptors (OKO-lab) with 2 ml of
medium supplemented with 25 mM HEPES, pH 7.4, and
placed on a heated stage at 378C, to be observed in bright
field either with a PlanApochromat 63 n.a. 1.4 oil objective
(Zeiss) on an Axiovert S100 TV2 microscope (Zeiss), or with
a 60 n.a. 1.4 oil objective (Olympus) on a Olympus IX70
microscope (DeltaVision System, Applied Precision). Each
coverslip was analysed for a total time not exceeding 1 h to
ensure properly buffered conditions (33). Cells treated with
cytochalasin D and nocodazole were incubated with the
drugs 30 min prior to observations and recorded up to 1 h
from the beginning of the treatment. Cells expressing
pEGFP-MC-LT were analyzed 24 h post-transfection by
choosing among the EGFP-positive cells those showing an
already evident dilute-like phenotype. Images were recorded
with a ORCA II CCD camera (Hamamatsu Photonics), using
Image-Pro Plus software (Media Cybernetics), or with a Cool-
SNAP CCD camera (Roper Scientific, Photometrics), using
softWoRx 3.5 software (Applied Precision). Each wild-type
and Oa1-deficient line to be compared were acquired in the
same conditions on the same day. ImageJ (plugin ‘Manual
tracking’) from NIH Image (http://rsb.info.nih.gov/ij/) was
used to track the melanosome paths. All data collected were
transferred and elaborated in an Excel worksheet (Microsoft).
A number of 50–100 distinct melanosomes were chosen ran-
domly in comparable areas of the cytoplasm of 5–12 different
Oa1þ/2 or Oa12/2 cells from two independent experiments,
and individual movements (or steps) were calculated as the
displacement between successive frames (resulting in 179
steps per organelle). Similarly, 40–50 distinct melanosomes
were analyzed from five different Oa1þ/þ or Oa12/2 cells,
or Oa12/2LOA1SN or Oa12/2LOA1D18SN cells. In
untreated conditions, melanosomes were selected based on
their position in the first frame within or outside of the peri-
nuclear area, defined as the cytoplasm within a 15-mm-radius
circle around the nucleus and corresponding to the
MT-enriched region in most cells (Fig. 5A, white circles). In
other conditions, melanosome motility was quite uniform
throughout the cytoplasm and organelles were chosen mostly
out of the perinuclear area, which is inconveniently thick
and crowded, particularly upon cytochalasin D treatment or
pEGFP-MC-LT expression. Movement direction was calcu-
lated relative to the centroid position of the nucleus, or of
the melanosome aggregate in pEGFP-MC-LT-transfected
cells. Some heterogeneity in melanosome size was present
both in wild-type and Oa1-deficient lines, however, this varia-
bility was definitively more pronounced in the latter, with mel-
anosomes showing various dimensions from normal (1 mm
or less) to clearly giant (2–3 mm). In initial trials, despite
the tracking of giant melanosomes was always avoided,
random sampling of organelles of normal and apparently
similar size resulted in the selection of melanosomes with
slightly, yet significantly, bigger average diameters in
Oa1-deficient lines compared with their wild-type counter-
parts (wild-type organelles were in average 1.5–2 pixels
smaller, corresponding to 0.15–0.2 mm). Since this physical
variable had an effect on the frequency of fast movements
(data not shown), we established a size range for melanosomes
to be analysed, corresponding to 7–9+ 1 pixels in the digital
movie acquisitions (corresponding to 0.7–0.9+ 0.1 mm),
for both major and minor diameters. The sizes of all tracked
melanosomes, chosen within the allowed range, were precisely
determined by two independent investigators by considering
as the melanosome margins the more external series of
pixels clearly distinct from the surrounding background and
extending for at least half of the organelle shape (Supplemen-
tary Material, Fig. S4). The dimensions of organelles obtained
from each wild-type cell line and its Oa1-deficient counterpart
were compared to exclude statistically significant differences.
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The average major and minor diameters and Student’s t-test
values of melanosomes analysed for each wild-type and
Oa1-deficient line in the different conditions are reported in
Supplementary Material, Table S1.
Electron microscopy
Cell culture monolayers were fixed for 15 min at 48C with 4%
paraformaldehyde and 2.5% glutaraldehyde in 125 mM phos-
phate buffer. The monolayers were detached by rubber and
centrifuged at high speed. The pellet was post-fixed for 1 h
with OsO4 in 125 mM phosphate buffer, washed, and
embedded in Epon. Conventional thin sections were collected
on uncoated grids, stained with uranyl and lead citrate, and
acquired by a CCD camera-equipped Leo912ab electron
microscope and AnalySIS software (Soft Imaging System).
Electron microscopy analysis of mouse retinas was performed
on comparable regions of the eyes from wild-type and
Oa1-KO mice belonging to the same litter and sacrificed at
the same time, as previously described (27,29). For quantifi-
cation of melanosome distribution, rectangular areas of RPE,
corresponding to few cells and delimited by the apical and
basal membranes, were divided transversely into apical zone
(corresponding to one-third of the total area) and cell body
(corresponding to the remaining two thirds), and the orga-
nelles contained within were counted. In case of slight irregu-
larities of the apical membrane, as in the Oa1-KO section
shown in Figure 1A, the external limit of the apical region
was placed at an intermediate position and the RPE cytoplasm
that remained excluded was calculated to compensate gaps in
the area of the apical zone under consideration. All quantitat-
ive analyses on organelle size, density and distribution were
performed considering mature melanosomes.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG Online.
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